74 related articles for article (PubMed ID: 3604838)
41. Detection of elastin-antielastin circulating immune complexes (CIC) in diabetic patients with vascular damage.
Baydanoff S; Nicoloff G; Russev T; Alexiev C
Cor Vasa; 1988; 30(5):361-7. PubMed ID: 3229119
[TBL] [Abstract][Full Text] [Related]
42. [Regulatory subpopulations of T-lymphocytes and blocking factors in the serum of patients with inoperable lung cancer treated with indomethacin].
Kas'ianenko IV; Pivniuk VM; Pivniuk NA
Eksp Onkol; 1987; 9(6):55-8. PubMed ID: 2893725
[TBL] [Abstract][Full Text] [Related]
43. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
44. [The cytochemical characteristics of neutrophil leukocytes in lung cancer before and during antineoplastic chemotherapy].
Gol'dberg VE; Kulagina IV; Gumilevskiĭ BIu; Dygaĭ AM
Lab Delo; 1991; (10):38-41. PubMed ID: 1722528
[TBL] [Abstract][Full Text] [Related]
45. [Parameters of humoral immunity in patients with breast carcinoma during therapy with leukocyte interferon].
Tomin R; Juranić Z; Spuzić I; Culafić M
Glas Srp Akad Nauka Med; 1991; (41):97-104. PubMed ID: 1916452
[TBL] [Abstract][Full Text] [Related]
46. [Immune complexes as markers in breast cancer and melanoma].
Cappellari A; Corradi G
Boll Ist Sieroter Milan; 1987; 66(4):303-7. PubMed ID: 3442620
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of circulating immune complexes in cancer patients.
Dass TK; Aziz M; Rattan A
Jpn J Cancer Res; 1991 Nov; 82(11):1284-91. PubMed ID: 1752784
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
51. Human lung cancer--a comparative study of the levels of circulating immune complexes in pulmonary blood draining the tumor area and peripheral venous blood.
Bukh A; Kimose HH; Aguado MT; Linnet L; Møller NP
Int J Cancer; 1989 May; 43(5):837-40. PubMed ID: 2714887
[TBL] [Abstract][Full Text] [Related]
52. Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes.
Bukh A; Aguado MT; Kimose HH; Mouritzen C; Møoller NP
Cancer; 1988 May; 61(10):2033-41. PubMed ID: 3258788
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of occurrence atypical proteins in the serum at smoking and non-smoking cigarettes patients with lung cancer].
Gołda R; Przybylski G; Dokładna W; Pyskir M; Pyskir J
Przegl Lek; 2013; 70(10):784-6. PubMed ID: 24501795
[TBL] [Abstract][Full Text] [Related]
54. [Circulating immune complexes in patients with lung cancer].
Li LS
Zhonghua Nei Ke Za Zhi; 1984 Jun; 23(6):349-51, 398. PubMed ID: 6510131
[No Abstract] [Full Text] [Related]
55. Circulating immune complexes in Hodgkin's disease.
Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
[TBL] [Abstract][Full Text] [Related]
56. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
Ronai Z; Shaham J; Stein J; Sulitzeanu D
Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
[TBL] [Abstract][Full Text] [Related]
57. Chemiluminescence production by neutrophils and immune complex levels in cancer patients.
Chasseing NA; Barañao RI; Fernández O; Bordenave H; Rumi LS
Cancer Invest; 1993; 11(5):517-22. PubMed ID: 8402220
[TBL] [Abstract][Full Text] [Related]
58. Levels of circulating immune complexes in patients with ovarian cancer.
Clarke AG; Vasey DP; Symonds EM; Faratian B; McLaughlin PJ; Price MR; Baldwin RW
Br J Obstet Gynaecol; 1982 Mar; 89(3):231-7. PubMed ID: 7066260
[TBL] [Abstract][Full Text] [Related]
59. Investigation of circulating immune complexes in patients with breast cancer.
Horváth M; Fekete B; Rahóty P
Oncology; 1982; 39(1):20-2. PubMed ID: 7058043
[TBL] [Abstract][Full Text] [Related]
60. Assay, isolation and characterization of circulating immune complexes from serum of gastrointestinal cancer, stage III and IV melanoma and chronic inflammatory bowel disease patients.
Bartoloni C; Guidi L; Pili R; Lewis ZA; Tricerri A; Cursi F; Gentiloni N; Cortesi E; Gambassi G
Oncology; 1993; 50(1):27-34. PubMed ID: 8421596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
